STI/HIV Hot Topics

STI/HIV Hot Topics

Antibiotic resistant STIs such as gonorrhea and Mycoplasma genitalium are of increasing concern, however, health professionals may not be aware of new therapies and alternative regimens to address these infections.  In 2025 two new oral therapies for gonorrhea were approved by the US FDA, which can be used in case of allergy to ceftriaxone.  Additionally there have been additional studies from Australia (Htaik et al 2025) that describe alterative regimens for MG treatment failure.  This session will inform providers about potential alternative therapies for antibiotic resistant STIs, as well as new developments in STI testing technology that will prepare them to accurately diagnose STIs and treat challenging cases. 
Additionally, there are now multiple oral and injectable regimens for HIV pre exposure prophylaxis, and a new biannual regimen, lenacapvir was recently recommended by the CDC for use in the US in the 2nd quarter of 2025.  Given the regimen is so new, health care providers may not be aware of pros/cons of each regimen and how to deliver counseling messages.  This session will discuss both oral and injectable PrEP regimens, including efficacy and side effects, so participants are prepared to counsel their patients on selection of biomedical HIV prevention medication. 

Session Information

Format: Internet live 
Date: March 18, 2026 
Time: 11:00 am - 12:00 pm ET

Format: Internet, self-paced 
Release Date: March 19, 2026
Expiration Date: March 18, 2028

After the expiration date, this session will no longer be accessible for viewing or downloading.
CE Credit/Contact Hours must be requested by the expiration date.

Cost:
FREE

Speaker(s)

Ina Park MD, MS
UC San Francisco

Intended Audience

• Advanced Practice Clinician
• Nurse
• Physician, Physician Assistant

Learning Objectives

After this session, participants should be able to:

1. Evaluate patients with urethral discharge and three potential antibiotic regimens for antibiotic resistant gonorrhea and Mycoplasma genitalium
2. Discuss changes to HPV and Hep B vaccine recommendations by the ACIP and how they compare to other professional societies.
3. Discuss common side effects of oral versus injectable PrEP regimens and recommendations regarding lenacapvir. 

Program Planning Committee 

Ina Park MD, MS
UC San Francisco

Robin Mills, MA, CHWC
UC Berkeley

Jozzy Rivera, BA
Michigan State University

Robert Stines, DNP, FNP-BC 
School of the Art Institute of Chicago

Brenda Masiga-Crowell, DNP, MBA, RN, CNL
Purdue University

For more information about this session or its speaker(s), contact education@acha.org.

Credit/Contact Hours and Disclosures

Types of Credit/Contact Hours Available

Refer to the Continuing Education Key.

• CME: 1.0

*Pharmacology credits, when available, are listed after the total number of nursing contact hours (e.g. CNE: 1.5/.75)

Deadlines

Claim your credit/contact hours or certificate on each session's Contents tab by the deadline.

If you attended the session LIVE: Credit/Contact Hours must be requested by April 8, 2026.

If you viewed the session as a RECORDING: Credit/Contact Hours must be requested by March 18, 2028.

Relevant Financial Relationships

None of the presenters or planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Successful Completion to Obtain Credit/Contact Hours (or certificate of attendance)

Criteria for successful completion is commensurate with participation and passing of a post-test with a minimum of an 80%.

Select the "Contents" tab above (registered users only) for access to the following components. It is estimated that it will require 60 minutes to view the webinar and complete the post-test. Credit/Contact Hours must be requested by the program expiration date (see "Overview" tab above).

Step 1:  View/Attend the session in its entirety.

Step 2:  Complete the mandatory Attestation and Post-test (passing score of 80%) for CE Credit/Contact Hours. See below for post-test passing requirements.

Step 3:  Select the certificate for the type of credit/contact hour you are requesting. Select "Certificate of Attendance" if no credit/contact hour is being requested. 

Continuing Education Statements 

Continuing Education

The American College Health Association (ACHA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ACHA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.

Policies 

Post-test Policy
It is the policy of the American College Health Association that when a post-test is required upon completion of a continuing education activity, participants must receive a passing grade of 80%. If participants receive a grade lower than 80%, they will be given the opportunity to re-take the post-test one time. If they receive 80% or higher the second time, they will be awarded continuing education credits/contact hours for the activity. We encourage participants to complete the post-test immediately after viewing the program.

Off-Label Product Use
This educational activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).

Non-endorsement
ACHA does not endorse any products or services that are displayed or referred to in conjunction with this activity and is not responsible for the actual presentation of content during scientific sessions.

Non-discrimination 
The American College Health Association (ACHA) supports institutional, as well as legislative or regulatory initiatives to promote a campus climate guided by the values of inclusion, respect, equality and equity. ACHA rejects all forms of intolerance and bias, whether implicit or explicit. Such a climate is essential to college health and wellbeing.

Consistent with these values, ACHA rejects all forms of discriminatory conduct with respect to: age; race/ethnicity; sex; sexual orientation; gender, including gender identity and expression; marital status; physical size; psychological/physical/learning ability; religious, spiritual or cultural identity; socioeconomic status; veteran status; or any other class of persons. ACHA actively strives to eliminate bias and discriminatory conduct from all its policies, procedures, communications, actions and activities.

Commercial Support

No commercial support has been received for this activity.